STERIS plc (NYSE:STE) Shares Bought by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC lifted its holdings in STERIS plc (NYSE:STE) by 335.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,727 shares of the medical equipment provider’s stock after purchasing an additional 16,737 shares during the period. OneDigital Investment Advisors LLC’s holdings in STERIS were worth $5,270,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in STE. Massachusetts Financial Services Co. MA boosted its holdings in shares of STERIS by 13.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 6,442,805 shares of the medical equipment provider’s stock worth $1,414,453,000 after buying an additional 778,613 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of STERIS by 7.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,738,630 shares of the medical equipment provider’s stock worth $390,880,000 after buying an additional 120,616 shares during the period. Impax Asset Management Group plc boosted its holdings in shares of STERIS by 29.7% in the second quarter. Impax Asset Management Group plc now owns 1,150,517 shares of the medical equipment provider’s stock worth $251,663,000 after buying an additional 263,383 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of STERIS by 9.5% in the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider’s stock worth $270,230,000 after buying an additional 96,336 shares during the period. Finally, Bessemer Group Inc. boosted its holdings in shares of STERIS by 1.8% in the first quarter. Bessemer Group Inc. now owns 960,219 shares of the medical equipment provider’s stock worth $215,879,000 after buying an additional 16,632 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Activity

In other news, CFO Michael J. Tokich sold 23,332 shares of STERIS stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the transaction, the chief financial officer now owns 42,930 shares of the company’s stock, valued at $10,603,710. This trade represents a 35.21 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

STE has been the subject of several research reports. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Wednesday, August 7th. Stephens restated an “overweight” rating and set a $260.00 price target on shares of STERIS in a report on Thursday, November 7th. Piper Sandler upgraded shares of STERIS from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Finally, KeyCorp raised their price target on shares of STERIS from $255.00 to $265.00 and gave the stock an “overweight” rating in a report on Tuesday, September 3rd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average target price of $253.00.

STERIS Price Performance

NYSE STE opened at $220.12 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $21.73 billion, a PE ratio of 50.26 and a beta of 0.85. The company has a 50 day moving average price of $230.77 and a two-hundred day moving average price of $228.15. STERIS plc has a 12-month low of $195.47 and a 12-month high of $248.24.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.12 by $0.02. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the previous year, the company earned $2.03 earnings per share. The company’s revenue was up 7.3% compared to the same quarter last year. As a group, equities analysts predict that STERIS plc will post 9.15 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th will be given a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Tuesday, November 19th. STERIS’s dividend payout ratio is 52.05%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.